Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)

M. Elkabets; S. Vora; D. Juric; N. Morse; M. Mino-Kenudson; T. Muranen; J. Tao; A. B. Campos; J. Rodon; Y. H. Ibrahim; V. Serra; V. Rodrik-Outmezguine; S. Hazra; S. Singh; P. Kim; C. Quadt; M. Liu; A. Huang; N. Rosen; J. A. Engelman; M. Scaltriti; J. Baselga

doi:10.1126/scitranslmed.aav9425

Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)

M. Elkabets
, S. Vora
, D. Juric
, N. Morse
, M. Mino-Kenudson
, T. Muranen
, J. Tao
, A. B. Campos
, J. Rodon
, Y. H. Ibrahim
, V. Serra
, V. Rodrik-Outmezguine
, S. Hazra
, S. Singh
, P. Kim
, C. Quadt
, M. Liu
, A. Huang
, N. Rosen
, J. A. Engelman

M. Scaltriti, J. Baselga

The Shraga Segal Department of Microbiology and Immunology

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the Research Article "mTORC1 Inhibition Is Required for Sensitivity to PI3K p110á Inhibitors in PIK3CA-Mutant Breast Cancer," the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Original language	English
Article number	eaav9425
Journal	Science Translational Medicine
Volume	10
Issue number	468
DOIs	https://doi.org/10.1126/scitranslmed.aav9425
State	Published - 14 Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Medicine

Access to Document

10.1126/scitranslmed.aav9425

Cite this

Elkabets, M., Vora, S., Juric, D., Morse, N., Mino-Kenudson, M., Muranen, T., Tao, J., Campos, A. B., Rodon, J., Ibrahim, Y. H., Serra, V., Rodrik-Outmezguine, V., Hazra, S., Singh, S., Kim, P., Quadt, C., Liu, M., Huang, A., Rosen, N., ... Baselga, J. (2018). Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747). Science Translational Medicine, 10(468), Article eaav9425. https://doi.org/10.1126/scitranslmed.aav9425

@article{6e52989f41094a1ab0669a5a756cb3cd,

title = "Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)",

abstract = "In the Research Article {"}mTORC1 Inhibition Is Required for Sensitivity to PI3K p110{\'a} Inhibitors in PIK3CA-Mutant Breast Cancer,{"} the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.",

author = "M. Elkabets and S. Vora and D. Juric and N. Morse and M. Mino-Kenudson and T. Muranen and J. Tao and Campos, \{A. B.\} and J. Rodon and Ibrahim, \{Y. H.\} and V. Serra and V. Rodrik-Outmezguine and S. Hazra and S. Singh and P. Kim and C. Quadt and M. Liu and A. Huang and N. Rosen and Engelman, \{J. A.\} and M. Scaltriti and J. Baselga",

note = "Publisher Copyright: Copyright {\textcopyright} 2018, American Association for the Advancement of Science.",

year = "2018",

month = nov,

day = "14",

doi = "10.1126/scitranslmed.aav9425",

language = "English",

volume = "10",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "468",

}

Elkabets, M, Vora, S, Juric, D, Morse, N, Mino-Kenudson, M, Muranen, T, Tao, J, Campos, AB, Rodon, J, Ibrahim, YH, Serra, V, Rodrik-Outmezguine, V, Hazra, S, Singh, S, Kim, P, Quadt, C, Liu, M, Huang, A, Rosen, N, Engelman, JA, Scaltriti, M & Baselga, J 2018, 'Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)', Science Translational Medicine, vol. 10, no. 468, eaav9425. https://doi.org/10.1126/scitranslmed.aav9425

Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747). / Elkabets, M.; Vora, S.; Juric, D. et al.
In: Science Translational Medicine, Vol. 10, No. 468, eaav9425, 14.11.2018.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum for the research article

T2 - mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)

AU - Elkabets, M.

AU - Vora, S.

AU - Juric, D.

AU - Morse, N.

AU - Mino-Kenudson, M.

AU - Muranen, T.

AU - Tao, J.

AU - Campos, A. B.

AU - Rodon, J.

AU - Ibrahim, Y. H.

AU - Serra, V.

AU - Rodrik-Outmezguine, V.

AU - Hazra, S.

AU - Singh, S.

AU - Kim, P.

AU - Quadt, C.

AU - Liu, M.

AU - Huang, A.

AU - Rosen, N.

AU - Engelman, J. A.

AU - Scaltriti, M.

AU - Baselga, J.

PY - 2018/11/14

Y1 - 2018/11/14

N2 - In the Research Article "mTORC1 Inhibition Is Required for Sensitivity to PI3K p110á Inhibitors in PIK3CA-Mutant Breast Cancer," the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

AB - In the Research Article "mTORC1 Inhibition Is Required for Sensitivity to PI3K p110á Inhibitors in PIK3CA-Mutant Breast Cancer," the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

UR - https://www.scopus.com/pages/publications/85056693806

U2 - 10.1126/scitranslmed.aav9425

DO - 10.1126/scitranslmed.aav9425

M3 - Comment/debate

AN - SCOPUS:85056693806

SN - 1946-6234

VL - 10

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 468

M1 - eaav9425

ER -

Elkabets M, Vora S, Juric D, Morse N, Mino-Kenudson M, Muranen T et al. Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747). Science Translational Medicine. 2018 Nov 14;10(468):eaav9425. doi: 10.1126/scitranslmed.aav9425

Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this